Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Stark AA, Zeiger E, Pagano DA
& Vousden, K
Miyata et al., 2016)
Representative GLP-1RAs are classified by their pharmacokinetic profiles: first-generation, short-acting formulations such as exenatide and lixisenatide are primarily utilized for postprandial glycemic control
Moreover, because discontinuation of GLP-1RAs often leads to weight regain, these medications must be regarded as a chronic therapy to sustain weight loss and prevent associated negative health outcomes
US$ 20.67
US$ 22.88
US$ 24.52
US$ 21.36
US$ 27.82
